Siltartoxatug Injection 10mg (Trinomab) – AR Grade Factory low price wholesale

$10.00

Trinomab Siltartoxatug Injection offers 10mg of active ingredient per 0.5ml vial. Manufactured by Zhuhai Tainuo Maibo Pharmaceutical Co., Ltd., and approved under China NMPA S20250012. Designed exclusively for experimental and laboratory research. Supports wholesale and retail orders.?For wholesale prices, other specifications and uses, please consult our staff?

Compare

描述

Siltartoxatug (Trinomab) is an injectable monoclonal antibody used in advanced experimental research focused on targeted immunotherapies and molecular oncology. This formulation delivers a precise 10mg dose per 0.5ml vial, enabling controlled studies of receptor binding, immune response modulation, and tumor microenvironment interactions.

Produced by Zhuhai Tainuo Maibo Pharmaceutical Co., Ltd., Siltartoxatug is approved by the China National Medical Products Administration (NMPA) under registration number S20250012. The product is strictly for research use only and not for clinical or human applications.

Contents hide

1 Product Specifications

2 Mechanism of Action & Research Applications

3 Side Effects (For Reference Only in Models)

4 Disclaimer

Product Specifications

Parameter	Details
Product Name	Siltartoxatug Injection (Trinomab)
Dosage Form	Injectable solution
Strength	10mg per 0.5ml vial
Packaging	Single vial
Approval Number	S20250012 (China NMPA)
Product Code	86985202000013
Manufacturer	Zhuhai Tainuo Maibo Pharmaceutical Co., Ltd.
Barcode	Not yet recorded
Intended Use	Laboratory research only
Storage Conditions	Store refrigerated at 2–8°C, protect from light

Mechanism of Action & Research Applications

Siltartoxatug (Trinomab) functions as a humanized monoclonal antibody targeting specific cellular receptors. It is widely employed in research to explore:

Targeted immunotherapy mechanisms
Receptor-ligand interaction dynamics
Modulation of immune checkpoints
Antibody-dependent cellular cytotoxicity (ADCC)
Tumor microenvironment studies

This product supports oncology, immunology, and molecular biology research aiming to develop new therapeutic approaches.

Side Effects (For Reference Only in Models)

In laboratory models, Siltartoxatug may induce:

Immune cell modulation
Altered cytokine expression
Possible off-target effects under experimental conditions

These side effects are observed under controlled research settings and do not represent clinical safety data.

Disclaimer

Siltartoxatug Injection (Trinomab) is intended exclusively for laboratory and experimental research. It is not approved for human or veterinary medical use. Use must comply with local research and safety regulations.

其他信息

重量	1 公斤
尺寸	26 × 23 × 26 厘米

评价

目前还没有评价

成为第一个“Siltartoxatug Injection 10mg (Trinomab) – AR Grade Factory low price wholesale” 的评价者

Q1: What is the main purpose of Siltartoxatug Injection (Trinomab)?

A1: Siltartoxatug Injection is mainly used for laboratory research to study targeted immunotherapy, receptor binding, and immune system modulation. For laboratory research use only.

Q2: What is the dosage form and strength of Siltartoxatug Injection?

A2: It is an injectable solution containing 10mg of active antibody per 0.5ml vial.

Q3: Can Siltartoxatug Injection be used in clinical treatment?

A3: No, it is strictly for experimental and laboratory research and is not intended for clinical or therapeutic use.

Q4: Who manufactures Siltartoxatug Injection (Trinomab)?

A4: Zhuhai Tainuo Maibo Pharmaceutical Co., Ltd. manufactures this product.

Q5: How should Siltartoxatug Injection be stored?

A5: Store in a refrigerator at 2–8°C and protect from light.

Q6: Is Siltartoxatug Injection approved by any regulatory body?

A6: Yes, it is approved by the China National Medical Products Administration (NMPA) with the number S20250012.

Q7: Are bulk purchases available for Siltartoxatug Injection?

A7: Yes, both wholesale and retail orders are supported.

Q8: Are COA and SDS available for Siltartoxatug Injection?

A8: Yes, these documents can be provided upon request.

Q9: What research areas is Siltartoxatug Injection commonly used in?

A9: It is commonly used in oncology, immunology, and molecular biology research.

Q10: What side effects have been observed in research models?

A10: Immune modulation and altered cytokine profiles have been noted in controlled lab studies.